BII HIghlights
[Featured Research] SiNOPSEE Theraputics
20 Jul 2020
[Featured Research] SiNOPSEE Theraputics
BII scientists, Prof. Chandra Verma and Dr. Srinivasaraghavan Kannan from the Atomistic Simulations and Design in Biology group, along with Prof. Uttam Surana (Research Director of IMCB) and Dr. Hong Hwa Lim (Senior Scientist in BTI) co-founded an A*STAR spinoff company, SiNOPSEE Theraputics in December 2017.
SiNOPSEE Therapeutics is a bio-pharmaceutical company focused on the discovery, design, and development of small molecular weight compounds for the treatment of chronic diseases such as cancer and ophthalmology.
They were recently featured on A*STAR Research website where Prof. Uttam Surana shared that they were working on developing drugs to block angiogenesis in cancer and degenerative eye conditions.
Read more here:
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.